Project Number 5P50AG016570-15 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for AUTOMATED HIPPOCAMPAL SEGMENTATION AND 3D HIPPOCAMPAL ANALYSES FOR EPIDEMIOLOGICA Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 8. Novel Analyses, Methodologies and Techniques for Biomarker Discovery and Validation Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator APOSTOLOVA, LIANA G Principal Investigator First Name LIANA Principal Investigator Last Name APOSTOLOVA Awardee Organization UNIVERSITY OF CALIFORNIA LOS ANGELES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-10-002: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $163,271 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository [AlzPED] Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer’s Models [AlzPED] Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo [AlzPED] Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer’s Disease Mouse Model [AlzPED] Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. [AlzPED] Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer’s Disease Pagination Previous page ‹‹ Page 2
